Keyword: R&D

Plant Construction & Process Technology

M&A in Pharma and CRO/CMO Industry

28.09.2017 - Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your...

Strategy & Management

Digital’s Transformative Power across R&D

27.09.2017 - The pharmaceutical industry is making a fundamental shift from a product- to a patient-outcome focused approach. Consequently, R&D organizations must also reflect this strategic...

Strategy & Management

Innovative Companies Have to Deal with Risks

27.09.2017 - Pharma Waldhof is active in the development and commercialization of active substances, key intermediates and reagents for multiple applications in the pharmaceutical, diagnostics...

Strategy & Management

Science that Enables Solutions for Clean Air, Improved Health and Sustainable Use of Resources

27.09.2017 - 2017 marks the 200th anniversary of UK specialty chemical and technology group Johnson Matthey which – back in 1817 – began as assayers, testing the purity of precious metals. In...

Strategy & Management

Cutting the Gordian Knot of Pharma Operating Model Complexity

27.09.2017 - Pharmaceutical companies have traditionally had complex operating models, but in recent years, complexity has reached a whole new level. Instead of continuously assessing their set...

Plant Construction & Process Technology

The Expanding Role of Contract Manufacturing

27.09.2017 - In the shifting pharmaceutical landscape, contract manufacturing organizations (CMOs) and big pharma could see significant benefits. The findings of a new A.T. Kearney study can...

Plant Construction & Process Technology

New Rules For Pharma

27.09.2017 - Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...

News

ADC Bio to Invest $11m on Bioconjugation Facility

26.09.2017 - ADC Biotechnology (ADC Bio) has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK. A substantial part of...